The Journal of Organic Chemistry
Featured Article
MHz, CDCl3): δ 166.9, 163.4, 137.9, 133.1, 126.6, 122.6, 118.8, 66.5,
25.6, 24.4, 20.3. HRMS (ESI-TOF) m/z: [M − Cl]+ calcd for
C22H26AlN2O2 377.1804, found 377.1813.
previously been reported. 1H NMR (400 MHz, CDCl3): δ 4.38 (qd, J
= 6.1, 4.0 Hz, 1H, 4a), 4.15 (ddd, J = 7.2, 6.3, 4.0 Hz, 1H, 3a), 3.20
(qd, J = 7.5, 4.0 Hz, 1H, 3a), 3.17−3.12 (m, 1H, 4a), 1.90−1.68 (m,
2H + 2H, 3a + 4a), 1.53 (d, J = 6.1 Hz, 3H, 4a), 1.37 (d, J = 7.5 Hz,
3H, 3a), 1.48−1.26 (m, 4H + 4H, 3a + 4a), 0.93−0.88 (m, 3H + 3H,
3a + 4a). 13C{1H} NMR (126 MHz, CDCl3): δ 172.2 (3a), 171.5
(4a), 79.7 (3a), 74.7 (4a), 57.7 (4a), 50.8 (3a), 33.9 (3a), 29.1 (4a),
27.5 (4a), 27.2 (3a), 22.5 (4a), 22.4 (3a), 20.4 (4a), 14.0 (3a), 13.9
(4a), 12.6 (3a).
5,5″-((1E,1′E)-((2,3-Dimethylbutane-2,3-diyl)bis(azanylylidene))-
bis(methanylylidene))bis(3-tert-butyl-2′,4′,6′-triisopropyl[1,1′-bi-
phenyl]-4-olate)aluminum Chloride (20, Precursor to 9j). Following
general procedure C, Et2AlCl (1.0 M, hexanes, 650 μL, 0.650 mmol)
was added to a suspension of 15 (281 mg, 0.334 mmol) in DCM (7.0
mL). After the solution was stirred at 22 °C, the volatiles were
removed in vacuo. The residue was broken up and dried in vacuo at 80
°C for 1 h to give 20 (254 mg, 84%) as a yellow powder. Mp: >200
°C. 1H NMR (500 MHz, CDCl3): δ 8.44 (s, 2H), 7.33 (d, J = 2.3 Hz,
2H), 7.09 (d, J = 4.8 Hz, 4H), 6.99 (d, J = 2.2 Hz, 2H), 2.97 (hept, J =
6.9 Hz, 2H), 2.79 (p, J = 6.9 Hz, 2H), 2.78 (p, J = 6.9 Hz, 2H), 1.61 (s,
6H), 1.58 (s, 18H), 1.41 (s, 6H), 1.34 (d, J = 6.9 Hz, 12H), 1.17 (d, J
= 6.9 Hz, 6H), 1.16 (d, J = 6.9 Hz, 6H), 1.12 (d, J = 6.8 Hz, 6H), 1.10
(d, J = 6.8 Hz, 6H). 13C{1H} NMR (126 MHz, CDCl3): δ 167.6,
163.6, 147.9, 147.6, 147.2, 141.4, 136.8, 135.7, 132.3, 129.0, 120.8,
120.6, 119.3, 66.4, 35.7, 34.4, 30.5, 30.4, 30.0, 25.8, 24.79, 24.77, 24.6,
24.33, 24.32, 24.27, 24.25. HRMS (ESI-TOF) m/z: [M − Cl]+ calcd
for C58H82AlN2O2 865.6186, found 865.6186.
3,3″-((1E,1′E)-([1,1′-Binaphthalene]-2,2′-diylbis(azanylylidene))-
bis(methanylylidene))bis(3′,5′-di-tert-butyl-5-methyl[1,1′-biphenyl]-
2-olate)aluminum Chloride (rac-5c, Precursor to rac-1c). Following
general procedure C, Et2AlCl (1.0 M, hexanes, 950 μL, 0.950 mmol)
was added to a solution of 16 (774 mg, 0.863 mmol) in DCM (8.0
mL) at 0 °C. After being stirred at 22 °C for 12 h, approximately half
of the solvent was removed in vacuo. The remainder was cooled to 0
°C, and the precipitate isolated by filtration. The solid, still kept at 0
°C, was washed with cold DCM, then cold pentane, and subsequently
dried in vacuo at 80 °C for 1 h to give rac-5c (549 mg, 66%) as a
yellow powder. Mp: >200 °C. 1H NMR (500 MHz, CDCl3, −55 °C):
δ 8.20 (s, 1H), 7.96 (s, 1H), 7.82 (d, J = 8.7 Hz, 1H), 7.76 (d, J = 8.3
Hz, 1H), 7.69−7.67 (m, 2H), 7.62 (s, 2H), 7.57 (d, J = 8.6 Hz, 1H),
7.30 (t, J = 7.7 Hz, 1H), 7.27−7.24 (m, 2H), 7.21 (s, 1H), 7.13 (s,
1H), 7.11−7.03 (m, 4H), 6.98−6.95 (m, 3H), 6.86 (d, J = 8.7 Hz,
1H), 6.67 (s, 2H), 1.99 (s, 3H), 1.97 (s, 3H), 1.01 (s, 18H), 0.83 (s,
18H). 13C{1H} NMR (126 MHz, CDCl3, −55 °C): δ 174.1, 168.9,
162.8, 159.3, 149.5, 149.4, 144.2, 143.9, 140.8, 138.9, 136.6, 136.5,
134.0, 133.2, 133.0, 132.45, 132.40, 132.3, 131.8, 131.7, 130.5, 129.4,
128.6, 128.4, 127.2, 127.0, 126.9, 126.8, 126.5, 126.28, 126.25, 126.23,
126.0, 125.9, 125.8, 125.24, 125.22, 124.9, 124.48, 124.45, 124.12,
124.05, 120.6, 120.2, 119.3, 118.7, 34.9, 34.6, 31.5, 31.2, 20.5, 20.4.
HRMS (ESI-TOF) m/z: [M − Cl]+ calcd for C64H66AlN2O2
921.4934, found 921.4906.
rac-(3R,4R)-4-Ethyl-3-methyloxetan-2-one (rac-3b) and rac-
(3R,4R)-4-Methyl-3-propyloxetan-2-one (rac-4b). General procedure
D was followed using 9f (18.6 mg, 0.0209 mmol, 7.21 mol %), THF
(0.6 mL), and rac-2b (25.0 mg, 0.290 mmol). After being stirred at 22
°C for 20 h, the crude reaction mixture was subjected to bulb-to-bulb
distillation to give a mixture of rac-3b and rac-4b (22.0 mg, 66%) as a
yellow oil. Analytical data for rac-3b9a and rac-4b42 have previously
1
been reported. H NMR (400 MHz, CDCl3): δ 4.41 (qd, J = 6.1, 4.0
Hz, 1H, 4b), 4.13 (td, J = 6.6, 4.0 Hz, 1H, 3b), 3.22 (qd, J = 7.5, 4.0
Hz, 1H, 3b), 3.13 (ddd, J = 8.4, 6.7, 4.0 Hz, 1H, 4b), 1.94−1.73 (m,
4H), 1.55 (d, J = 6.1 Hz, 3H, 4b), 1.39 (d, J = 7.5 Hz, 3H, 3b), 1.03 (t,
J = 7.5 Hz, 3H, 3b), 1.00 (t, J = 7.6 Hz, 3H, 4b). 13C{1H} NMR (126
MHz, CDCl3): δ 172.1 (3b), 171.2 (4b), 80.6 (3b), 74.2 (4b), 59.0
(4b), 50.4 (3b), 27.3 (3b), 21.0 (4b), 20.4 (4b), 12.7 (3b), 11.2 (4b),
9.1 (3b).
rac-(3R,4R)-3-Methyl-4-propyloxetan-2-one (rac-3c) and rac-
(3R,4R)-3-Ethyl-4-methyloxetan-2-one (rac-4c). General procedure
D was followed using 9f (18.6 mg, 0.0209 mmol, 6.74 mol %), THF
(0.6 mL), and rac-3c (31.0 mg, 0.310 mmol). After being stirred at 22
°C for 20 h, the crude reaction mixture was subjected to flash column
chromatography to give a mixture of rac-3c and rac-4c (22.0 mg, 66%)
as a yellow oil. Analytical data for rac-3c9a and rac-4c43 have previously
1
been reported. H NMR (300 MHz, CDCl3): δ 4.40 (qd, J = 6.1, 3.9
Hz, 1H, 4c), 4.18 (ddd, J = 7.3, 6.2, 4.0 Hz, 1H, 3c), 3.24−3.14 (m,
2H), 1.89−1.78 (m, 2H), 1.76−1.65 (m, 2H), 1.55 (d, J = 6.1 Hz, 3H,
4c), 1.50−1.34 (m, 4H), 1.38 (d, J = 7.5 Hz, 3H, 3c), 0.98 (t, J = 7.5
Hz, 3H, 3c), 0.95 (t, J = 7.3 Hz, 3H, 4c). 13C{1H} NMR (126 MHz,
CDCl3): δ 172.2 (3c), 171.4 (4c), 79.5 (3c), 74.7 (4c), 57.5 (4c), 50.8
(3c), 36.2 (3c), 29.8 (4c), 20.4 (4c), 20.3 (4c), 18.5 (3c), 13.80 (3c),
13.79 (4c), 12.6 (3c).
rac-(3R,4R)-3-Methyl-4-pentyloxetan-2-one (rac-3d) and rac-
(3R,4R)-4-Methyl-3-pentyloxetan-2-one (rac-4d). General procedure
D was followed using 9f (17.8 mg, 0.0200 mmol, 6.58 mol %), THF
(0.6 mL), and rac-2d (39.0 mg, 0.304 mmol). After being stirred at 22
°C for 20 h, the crude reaction mixture was subjected to flash column
chromatography to give a mixture of rac-3d and rac-4d (35.2 mg, 74%)
as a colorless oil. Analytical data for rac-3d44 and rac-4d16 have
previously been reported. 1H NMR (400 MHz, CDCl3): δ 4.38 (qd, J
= 6.1, 3.9 Hz, 1H, 4d), 4.16 (td, J = 6.7, 4.0 Hz, 1H, 3d), 3.20 (qd, J =
7.6, 4.0 Hz, 1H, 3d), 3.16 (ddd, J = 8.9, 6.5, 3.9 Hz, 1H, 4d), 1.89−
1.79 (m, 2H), 1.78−1.6 (m, 2H), 1.54 (d, J = 6.0 Hz, 3H, 4d), 1.48−
1.24 (m, 12H), 1.38 (d, J = 7.5 Hz, 3H, 3d), 0.90−0.86 (m, 6H).
13C{1H} NMR (75 MHz, CDCl3): δ 172.2 (3d), 171.5 (4d), 79.7
6,6′-((1E,1′E)-((2,3-Dimethylbutane-2,3-diyl)bis(azanylylidene))-
35
bis(methanylylidene))bis(2,4-di-tert-butylphenolate)aluminum Co-
baltate (9f). NaCo(CO)4 (33.4 mg, 0.172 mmol), 6,6′-((1E,1′E)-
((2,3-dimethylbutane-2,3-diyl)bis(azanylylidene))bis(methanylyl-
idene))bis(2,4-di-tert-butylphenolate)aluminum chloride13 (100 mg,
0.164 mmol), and THF (2.5 mL) were mixed and stirred for 12 h at 22
°C. The reaction mixture was filtered through a 0.45 μm Teflon
syringe filter and the filtrate carefully layered with hexane and then
placed in a freezer at −34 °C for a day. The resulting crystals were
isolated by filtration, washed with hexanes, and then dried in vacuo to
give 9f (118 mg, 81%) as yellow crystals. 1H NMR (400 MHz, C6D6):
δ 8.75 (s, 2H), 7.87 (d, J = 2.6 Hz, 2H), 7.78 (d, J = 2.5 Hz, 2H),
3.47−3.23 (m, 8H, THF), 1.65 (s, 18H), 1.43 (s, 18H), 1.18 (s, 12H),
1.20−1.15 (m, 8H, THF). 13C{1H} NMR (126 MHz, C6D6 + THF-d8,
(1:1, v/v)): δ 171.0, 162.4, 139.4, 132.2, 130.5, 128.2, 119.9, 67.9
(THF), 67.6, 35.8, 34.5, 31.5, 29.8, 26.3, 25.9 (THF). IR (neat, cm−1):
1862.1 ν(CO). Anal. Calcd for C48H70AlCoN2O8: C, 64.85; H, 7.94;
N, 3.15. Found: C, 65.00; H, 8.18; N, 3.02.
(3d), 74.8 (4d), 57.7 (4d), 50.8 (3d), 34.2 (3d), 31.50 (4d), 31.46
(3d), 27.7 (4d), 26.6 (4d), 24.7 (3d), 22.54 (3d), 22.46 (4d), 20.4
(4d), 14.04 (4d), 14.02 (3d), 12.6 (3d).
rac-(3R,4R)-4-Hexyl-3-methyloxetan-2-one (rac-3e) and rac-
(3R,4R)-3-Hexyl-4-methyloxetan-2-one (rac-4e). General procedure
D was followed using 9f (13.3 mg, 0.0150 mmol, 5.02 mol %), THF
(0.6 mL), and rac-2e (42.5 mg, 0.299 mmol). After being stirred at 22
°C for 20 h, the crude reaction mixture was subjected to flash column
chromatography to give a mixture of rac-3e and rac-4e (48.3 mg, 95%)
as a colorless oil. Analytical data for rac-3e45 and rac-4e16 have
previously been reported. 1H NMR (300 MHz, CDCl3): δ 4.38 (qd, J
= 6.1, 4.0 Hz, 1H, 4e), 4.15 (td, J = 6.6, 3.9 Hz, 1H, 3e), 3.20 (qd, J =
7.5, 4.0 Hz, 1H, 3e), 3.14 (ddd, J = 8.9, 6.5, 3.9 Hz, 1H, 4e), 1.88−1.78
(m. 2H), 1.78−1.65 (m. 2H), 1.54 (d, J = 6.1 Hz, 3H), 1.47−1.21 (m,
16H), 1.37 (d, J = 7.6 Hz, 3H), 0.89−0.85 (m, 6H). 13C{1H} NMR
(75 MHz, CDCl3): δ 172.2 (3e), 171.5 (4e), 79.7 (3e), 74.7 (4e), 57.7
(4e), 50.8 (3e), 34.2 (3e), 31.7 (3e), 31.6 (4e), 29.00 (4e), 28.96
rac-(3R,4R)-4-Butyl-3-methyloxetan-2-one (rac-3a) and rac-
(3R,4R)-3-Butyl-4-methyloxetan-2-one (rac-4a). General procedure
D was followed using 9f (13.3 mg, 0.0150 mmol, 4.93 mol %), THF
(0.6 mL), and rac-2a (34.7 mg, 0.304 mmol). After being stirred at 22
°C for 20 h, the crude reaction mixture was subjected to flash column
chromatography to give a mixture of rac-3a and rac-4a (34.7 mg, 80%)
as a colorless oil. Analytical data for rac-3a9a and rac-4a16 have
H
dx.doi.org/10.1021/jo501899e | J. Org. Chem. XXXX, XXX, XXX−XXX